The first experimental application of enantioselective Raman spectroscopy (esR) is demonstrated using the example of the chiral alcohol 2-butanol. Samples of the neat enantiomers and the racemic mixture were analyzed in a self-built Raman set-up. The Raman spectrum allows the discrimination of the chemical species. It is shown that the optical rotation of a Raman peak with a small depolarization ratio can be measured. In addition, without any sample modification, e.g. chiral solvent, the enantiomers are distinguishable at a suitable half-wave retarder angle detecting only the vertically polarized component of the Raman signal.
Adding imidazolium ionic liquids to polar solvents such as alkyl alcohols usually results in the dissociation of ion pairs as cation–anion interactions are replaced, e.g., by ion⋯OH hydrogen bonds. In this Communication, we apply Raman scattering and infrared absorption spectroscopy to an example binary system comprising 1-butyl-3-methylimidazolium trifluoromethanesulfonate (triflate) and propan-1-ol. The spectra are analyzed using principal component analysis (PCA), excess spectroscopy, and spectral decomposition. The results provide evidence that the ion pairs of the ionic liquid do not dissociate in propan-1-ol, even at high dilution. Moreover, there are clear signs that the propan-1-ol hydrogen bonding network is disrupted in the presence of the ionic liquid as the hydroxyl groups predominantly interact with the sulfonate oxygen atoms.
Principal component analysis (PCA) applied to enantioselective Raman (esR) spectroscopy data enhances the performance of the method and opens up opportunities for a fully automatic data evaluation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.